Profiling of tumor infiltrates revealed that anti-CTLA4 blockade increased the percentage of both CD4+ and CD8+ T cells in wild-type mice over isotype (Supplementary Fig. 3a, b). The gene discussed is CTLA4; the disease is neoplasm.